tiprankstipranks
Trending News
More News >
Olympus Corp. (JP:7733)
:7733
Japanese Market
Advertisement

Olympus (7733) Stock Forecast & Price Target

Compare
6 Followers
See the Price Targets and Ratings of:

7733 Analyst Ratings

Moderate Buy
6Ratings
Moderate Buy
4 Buy
2 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Olympus
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

7733 Stock 12 Month Forecast

Average Price Target

¥2,178.47
▲(21.60% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Olympus in the last 3 months. The average price target is ¥2,178.47 with a high forecast of ¥2,503.69 and a low forecast of ¥2,002.95. The average price target represents a 21.60% change from the last price of ¥1,791.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1705":"¥1,705","1964":"¥1,964","2223":"¥2,223","2482":"¥2,482","2741":"¥2,741"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2503.68731565575,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥2.50K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2178.4660767149,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥2.18K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2002.9498525246,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥2.00K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1705,1964,2223,2482,2741],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1824.5,1876.7451781273653,1928.9903562547308,1981.2355343820961,2033.4807125094615,2085.725890636827,2137.9710687641923,2190.2162468915576,2242.461425018923,2294.706603146288,2346.951781273654,2399.1969594010193,2451.4421375283846,{"y":2503.68731565575,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1824.5,1851.7281597473,1878.9563194946,1906.1844792419,1933.4126389891999,1960.6407987364998,1987.8689584837998,2015.0971182311,2042.3252779784,2069.5534377257,2096.7815974729997,2124.0097572203,2151.2379169675996,{"y":2178.4660767149,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1824.5,1838.2269117326616,1851.953823465323,1865.6807351979846,1879.407646930646,1893.1345586633076,1906.8614703959693,1920.5883821286307,1934.3152938612923,1948.042205593954,1961.7691173266153,1975.496029059277,1989.2229407919383,{"y":2002.9498525246,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2163.345,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2517.301,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2529.182,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2740.567,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2638.092,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2320.769,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2343.541,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2026.712,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1925,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1906.5,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1840,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1706.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1824.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target¥2,504Average Price Target¥2,178Lowest Price Target¥2,003
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JP:7733
TipRanks AITipRanks
Not Ranked
TipRanks
¥2,048
Buy
14.32%
Upside
Reiterated
08/07/25
Olympus scores well due to its strong financial performance, characterized by robust revenue growth and solid profitability metrics. Technical analysis indicates short-term bullish momentum, though longer-term resistance is present. The valuation is reasonable, with a moderate P/E ratio and low dividend yield. The absence of earnings call data and corporate events does not impact the overall score.
Macquarie Analyst forecast on JP:7733
Tony RenMacquarie
Macquarie
¥2,800¥2,000
Hold
11.64%
Upside
Downgraded
08/04/25
Olympus (OCPNF) was downgraded to a Hold Rating at Macquarie
Goldman Sachs Analyst forecast on JP:7733
Akinori UedaGoldman Sachs
Goldman Sachs
¥2,500¥2,200
Buy
22.80%
Upside
Reiterated
07/18/25
Olympus (OCPNF) Gets a Buy from Goldman Sachs
J.P. Morgan Analyst forecast on JP:7733
Naoko SaitoJ.P. Morgan
J.P. Morgan
¥2,350
Buy
31.17%
Upside
Reiterated
07/02/25
J.P. Morgan Keeps Their Buy Rating on Olympus (OCPNF)
Morgan Stanley Analyst forecast on JP:7733
Ryotaro HayashiMorgan Stanley
Morgan Stanley
¥2,000
Buy
11.64%
Upside
Reiterated
06/28/25
Morgan Stanley Keeps Their Buy Rating on Olympus (OCPNF)
Citi
¥3,000¥2,500
Buy
39.55%
Upside
Reiterated
06/02/25
Citi Remains a Buy on Olympus (OCPNF)
Nomura
¥2,200¥2,000
Hold
11.64%
Upside
Reiterated
05/22/25
Olympus Corporation (7733:JP) (OCPNY) PT Lowered to JPY2,000 at Nomura/InstinetNomura/Instinet analyst Takahiro Mori lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,000.00 (from JPY2,200.00) while maintaining a Neutral rating.
Jefferies
¥1,900
Hold
6.06%
Upside
Downgraded
04/22/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Olympus (Other OTC: OCPNF) and Corvus Pharmaceuticals (NASDAQ: CRVS)
CLSA
¥2,700¥2,850
Buy
59.08%
Upside
Reiterated
11/13/24
Olympus Corporation (7733:JP) (OCPNY) PT Raised to JPY2,850 at CLSACLSA analyst Michael Luo raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,850.00 (from JPY2,700.00) while maintaining a Outperform (2) rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on JP:7733
TipRanks AITipRanks
Not Ranked
TipRanks
¥2,048
Buy
14.32%
Upside
Reiterated
08/07/25
Olympus scores well due to its strong financial performance, characterized by robust revenue growth and solid profitability metrics. Technical analysis indicates short-term bullish momentum, though longer-term resistance is present. The valuation is reasonable, with a moderate P/E ratio and low dividend yield. The absence of earnings call data and corporate events does not impact the overall score.
Macquarie Analyst forecast on JP:7733
Tony RenMacquarie
Macquarie
¥2,800¥2,000
Hold
11.64%
Upside
Downgraded
08/04/25
Olympus (OCPNF) was downgraded to a Hold Rating at Macquarie
Goldman Sachs Analyst forecast on JP:7733
Akinori UedaGoldman Sachs
Goldman Sachs
¥2,500¥2,200
Buy
22.80%
Upside
Reiterated
07/18/25
Olympus (OCPNF) Gets a Buy from Goldman Sachs
J.P. Morgan Analyst forecast on JP:7733
Naoko SaitoJ.P. Morgan
J.P. Morgan
¥2,350
Buy
31.17%
Upside
Reiterated
07/02/25
J.P. Morgan Keeps Their Buy Rating on Olympus (OCPNF)
Morgan Stanley Analyst forecast on JP:7733
Ryotaro HayashiMorgan Stanley
Morgan Stanley
¥2,000
Buy
11.64%
Upside
Reiterated
06/28/25
Morgan Stanley Keeps Their Buy Rating on Olympus (OCPNF)
Citi
¥3,000¥2,500
Buy
39.55%
Upside
Reiterated
06/02/25
Citi Remains a Buy on Olympus (OCPNF)
Nomura
¥2,200¥2,000
Hold
11.64%
Upside
Reiterated
05/22/25
Olympus Corporation (7733:JP) (OCPNY) PT Lowered to JPY2,000 at Nomura/InstinetNomura/Instinet analyst Takahiro Mori lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,000.00 (from JPY2,200.00) while maintaining a Neutral rating.
Jefferies
¥1,900
Hold
6.06%
Upside
Downgraded
04/22/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Olympus (Other OTC: OCPNF) and Corvus Pharmaceuticals (NASDAQ: CRVS)
CLSA
¥2,700¥2,850
Buy
59.08%
Upside
Reiterated
11/13/24
Olympus Corporation (7733:JP) (OCPNY) PT Raised to JPY2,850 at CLSACLSA analyst Michael Luo raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,850.00 (from JPY2,700.00) while maintaining a Outperform (2) rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Olympus

1 Month
xxx
Success Rate
4/7 ratings generated profit
57%
Average Return
-1.26%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of -1.26% per trade.
3 Months
xxx
Success Rate
5/7 ratings generated profit
71%
Average Return
+3.84%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +3.84% per trade.
1 Year
Naoko SaitoJ.P. Morgan
Success Rate
2/7 ratings generated profit
29%
Average Return
-6.34%
reiterated a buy rating last month
Copying Naoko Saito's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -6.34% per trade.
2 Years
xxx
Success Rate
0/7 ratings generated profit
0%
Average Return
-16.46%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -16.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

7733 Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
4
5
5
10
11
Buy
0
0
0
0
0
Hold
4
4
6
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
9
11
13
14
In the current month, 7733 has received 11 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 7733 average Analyst price target in the past 3 months is 2,178.47.
Each month's total comprises the sum of three months' worth of ratings.

7733 Financial Forecast

7733 Earnings Forecast

Next quarter’s earnings estimate for 7733 is ¥19.93 with a range of ¥17.98 to ¥22.35. The previous quarter’s EPS was ¥60.75. 7733 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year 7733 has Preformed in-line its overall industry.
Next quarter’s earnings estimate for 7733 is ¥19.93 with a range of ¥17.98 to ¥22.35. The previous quarter’s EPS was ¥60.75. 7733 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year 7733 has Preformed in-line its overall industry.

7733 Sales Forecast

Next quarter’s sales forecast for 7733 is ¥238.09B with a range of ¥232.40B to ¥243.30B. The previous quarter’s sales results were ―. 7733 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 53.52% of the time in the same period. In the last calendar year 7733 has Preformed in-line its overall industry.
Next quarter’s sales forecast for 7733 is ¥238.09B with a range of ¥232.40B to ¥243.30B. The previous quarter’s sales results were ―. 7733 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 53.52% of the time in the same period. In the last calendar year 7733 has Preformed in-line its overall industry.

7733 Stock Forecast FAQ

What is JP:7733’s average 12-month price target, according to analysts?
Based on analyst ratings, Olympus Corp.’s 12-month average price target is 2,178.47.
    What is JP:7733’s upside potential, based on the analysts’ average price target?
    Olympus Corp. has 21.60% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Olympus Corp. a Buy, Sell or Hold?
          Olympus Corp. has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Olympus Corp.’s share price target?
            The average share price target for Olympus Corp. is 2,178.47. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ¥2,503.69 ,and the lowest forecast is ¥2,002.95. The average share price target represents 21.60% Increase from the current price of ¥1,791.5.
              What do analysts say about Olympus Corp.?
              Olympus Corp.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of Olympus Corp.?
                To buy shares of JP:7733, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis